Advertisement
UK markets open in 5 hours 43 minutes
  • NIKKEI 225

    37,606.53
    -21.95 (-0.06%)
     
  • HANG SENG

    17,284.54
    0.00 (0.00%)
     
  • CRUDE OIL

    83.87
    +0.30 (+0.36%)
     
  • GOLD FUTURES

    2,340.20
    -2.30 (-0.10%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,183.93
    -426.41 (-0.83%)
     
  • CMC Crypto 200

    1,388.71
    +6.14 (+0.44%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Could This News Spark a Turnaround for Ocugen?

Could This News Spark a Turnaround for Ocugen?

Ocugen (NASDAQ: OCGN) shares were flying high earlier this year. The company signed a deal with India's Bharat Biotech for co-commercialization rights to its coronavirus vaccine candidate in the U.S. The Bharat product was close to market. Since then, Ocugen learned it wouldn't win the right to sell the vaccine in the U.S. as soon as it had hoped.